Steven E. Benner, MD, Senior Vice President and Global Therapeutic Head for Oncology at Astellas Oncology the future of treatment for metastatic urothelial cancer at the 2017 ASCO Annual Meeting in Chicago, IL.
Use of Checkpoint Inhibitors for Metastatic Urothelial Cancer
